AI assistant
Sending…
DATA I/O CORP — Director's Dealing 2005
Nov 7, 2005
34782_dirs_2005-11-07_2d95e283-0c1c-4a3d-a3cc-0797a50c7d57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: DATA I/O CORP (DAIO)
CIK: 0000351998
Period of Report: 2005-10-28
Reporting Person: Weigelt Harald (Vice President World Wide Sale)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 18352 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $2.453 | 2005-12-08 | Common Stock (3000) | Direct | |
| Employee Stock Option (right to buy) | $2.4065 | 2009-01-29 | Common Stock (5000) | Direct | |
| Employee Stock Option (right to buy) | $3.469 | 2006-12-08 | Common Stock (5000) | Direct | |
| Employee Stock Option (right to buy) | $1.33 | 2008-04-25 | Common Stock (7500) | Direct | |
| Employee Stock Option (right to buy) | $1.00 | 2009-04-17 | Common Stock (15000) | Direct | |
| Employee Stock Option (right to buy) | $2.93 | 2010-06-17 | Common Stock (15000) | Direct | |
| Employee Stock Option (right to buy) | $2.49 | 2011-06-21 | Common Stock (15000) | Direct |
Footnotes
F1: The option is exercisable in 16 equal quarterly installments. The first installment became exercisable on 7/25/2002.
F2: The option is exercisable in 16 equal quarterly installments. The first installment became exercisable on 7/17/2003.
F3: The option is exercisable in 16 equal quarterly installments. The first installment became exercisable on 9/17/2004.
F4: The option is exercisable in 16 equal quarterly installments. The first installment became exercisable on 9/21/2005.
More from DATA I/O CORP
Annual Report
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 30
Annual Report
2026
Apr 16
Regulatory Filings
2026
Apr 8